CGEM
Cullinan Oncology LLC
16.00$
+3.4%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +62.8% | -11.4% | -14.5% | +75.5% | +233.3% | -1.3% | +1.6% | |
| – | – | – | – | – | – | – | +87,605.9% | +63.5% | +14.7% | +8.9% | +24.3% | -4.7% | |
| – | – | -69.0% | +707.3% | -83.2% | +10,578.0% | -276.6% | – | +61.3% | +14.8% | – | – | – | |
| – | – | – | – | – | – | -60.9% | +4,974.8% | -151.7% | – | -103.0% | – | – | |
| – | – | – | – | – | – | -92.3% | -50.0% | +5,792.3% | +92.3% | -81.6% | -100.0% | – | |
| – | – | – | – | – | – | +13,463.2% | -84.7% | +6,058.2% | – | -85.6% | -480.7% | – | |
| – | – | +0.0% | +0.0% | +0.0% | -102.1% | +1,700.0% | -43.7% | – | -108.7% | – | – | – | |
| – | – | -87.1% | -76.5% | -3,548.2% | – | – | +0.0% | +0.0% | -1,357.1% | – | -100.0% | – | |
| – | +404.2% | -87.1% | -76.5% | +941.5% | -112.7% | – | +63.5% | +91.8% | -109.6% | – | +553.2% | -99.6% | |
| – | – | -104.8% | – | – | – | – | +256.7% | -203.3% | – | -159.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.